These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26174900)

  • 61. Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients.
    Billing H; Rieger S; Ovens J; Süsal C; Melk A; Waldherr R; Opelz G; Tönshoff B
    Transplantation; 2008 Nov; 86(9):1214-21. PubMed ID: 19005402
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Withdrawing of IVIG compound from the market].
    Shoenfeld Y
    Harefuah; 2010 Dec; 149(12):754-5. PubMed ID: 21916093
    [No Abstract]   [Full Text] [Related]  

  • 63. Incidence and risk factors for intravenous immunoglobulin-related hemolysis: A systematic review of clinical trial and real-world populations.
    Cuesta H; El Menyawi I; Hubsch A; Hoefferer L; Mielke O; Gabriel S; Shebl A
    Transfusion; 2022 Sep; 62(9):1894-1907. PubMed ID: 35916266
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intravenous immunoglobulin in the management of hemolytic disease of the newborn.
    Mundy CA
    Neonatal Netw; 2005; 24(6):17-24. PubMed ID: 16383181
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of isoagglutinins in intravenous immunoglobulin-related hemolysis.
    Bellac CL; Hottiger T; Jutzi MP; Bögli-Stuber K; Sänger M; Hanschmann KM; Keller-Stanislawski B; Funk MB
    Transfusion; 2015 Jul; 55 Suppl 2():S13-22. PubMed ID: 26174892
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hemoglobinuria and acute kidney injury requiring hemodialysis following intravenous immunoglobulin infusion.
    Welles CC; Tambra S; Lafayette RA
    Am J Kidney Dis; 2010 Jan; 55(1):148-51. PubMed ID: 19628320
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mechanisms of action of intravenous immune globulin in immune-mediated diseases.
    Mouthon L; Kaveri SV; Spalter SH; Lacroix-Desmazes S; Lefranc C; Desai R; Kazatchkine MD
    Clin Exp Immunol; 1996 May; 104 Suppl 1():3-9. PubMed ID: 8625540
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Massive intravascular haemolysis after high dose intravenous immunoglobulin therapy.
    Mohamed M; Bates G; Eastley B
    Br J Haematol; 2013 Mar; 160(5):570. PubMed ID: 23294261
    [No Abstract]   [Full Text] [Related]  

  • 69. Immunoglobulin-induced hemolysis, splenomegaly and inflammation in patients with antibody deficiencies.
    Pulvirenti F; Granata G; Girelli G; Quinti I
    Expert Rev Clin Immunol; 2016 Jul; 12(7):725-31. PubMed ID: 26854522
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antibody specific for the glycophorin A complex mediates intravenous immune globulin-resistant anemia in a murine model.
    Chen X; Ghaffar H; Jen CC; Lazarus AH
    Transfusion; 2014 Mar; 54(3):655-64. PubMed ID: 23782137
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intravenous immunoglobulin for the treatment of Crohn's disease.
    Rogosnitzky M; Danks R; Holt D
    Autoimmun Rev; 2012 Dec; 12(2):275-80. PubMed ID: 22579561
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Renal and hematologic side effects of long-term intravenous immunoglobulin therapy in patients with neurologic disorders.
    Levine AA; Levine TD; Clarke K; Saperstein D
    Muscle Nerve; 2017 Dec; 56(6):1173-1176. PubMed ID: 28520084
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Drug induced aseptic meningitis caused by intravenous immunoglobulin therapy.
    Mullane D; Williams L; Merwick A; Tobin WO; McGuigan C
    Ir Med J; 2012 Jun; 105(6):182-3. PubMed ID: 22973657
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ABO-immunoglobulin G antibodies in intravenous immune globulin can interfere in ABO-mismatched kidney transplants.
    Boctor FN; Bhaskaran M; Sheahan B; Heaton WA; Molmenti E
    Transfusion; 2011 Aug; 51(8):1874-5. PubMed ID: 21831188
    [No Abstract]   [Full Text] [Related]  

  • 76. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
    Sapir T; Carp H; Shoenfeld Y
    Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Hemolysis during immunoglobulin therapy].
    Muñoz J; García A; Jordán C; Rubió A; Ferrán C; Martínez Matos JA
    Sangre (Barc); 1996 Feb; 41(1):72-3. PubMed ID: 8779043
    [No Abstract]   [Full Text] [Related]  

  • 78. Intravenous immunoglobulin therapy for neuromuscular disorders.
    Ross MA
    Semin Neurol; 2007 Sep; 27(4):340-6. PubMed ID: 17701871
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Don't neglect the rare adverse event with intravenous immunoglobulin: Hemolytic anemia.
    Ucar İ; Koyuncu MB; Solmaz AA; Ugurludogan AC; Mercan S; Kucuk M; Unal T; Mazman S; Atilla E
    Transfus Clin Biol; 2023 Feb; 30(1):11-15. PubMed ID: 36028153
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anti-inflammatory activity of intravenous immunoglobulin through scavenging of heme.
    Wiatr M; Merle NS; Boudhabhay I; Poillerat V; Rossini S; Lecerf M; Kaveri SV; Lacroix-Desmazes S; Roumenina LT; Dimitrov JD
    Mol Immunol; 2019 Jul; 111():205-208. PubMed ID: 31078967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.